- Trials with a EudraCT protocol (15)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
15 result(s) found for: Causes of seizures.
Displaying page 1 of 1.
EudraCT Number: 2013-001858-10 | Sponsor Protocol Number: YKP3089C017 | Start Date*: 2013-10-21 |
Sponsor Name:SK Life Science, Inc. | ||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose- Response Trial of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures, with Optional Open-Label Extension | ||
Medical condition: Partial Onset Epilepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) DE (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) HU (Completed) PL (Completed) BG (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-002929-78 | Sponsor Protocol Number: CARISEPY3007- Amendment INT-2/GBR-1 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:Ortho-McNeil Janssen Scientific Affairs, LLC | |||||||||||||
Full Title: A Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy i... | |||||||||||||
Medical condition: Partial onset seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) CZ (Prematurely Ended) BE (Completed) FI (Completed) FR (Completed) IT (Prematurely Ended) ES (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000882-19 | Sponsor Protocol Number: P160949J | Start Date*: 2020-07-15 |
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | ||
Full Title: Efficacy of add-on PEramPanel in focal motor Status epilepticus | ||
Medical condition: Patients with a focal motor status epilepticus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001859-67 | Sponsor Protocol Number: YKP3089C021 | Start Date*: 2015-11-16 |
Sponsor Name:SK Life Science Inc | ||
Full Title: An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures | ||
Medical condition: Partial-onset epilepsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Restarted) BG (Completed) PL (Completed) CZ (Completed) HU (Completed) SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-000838-34 | Sponsor Protocol Number: NOE-TCS-201 | Start Date*: 2023-04-04 | |||||||||||
Sponsor Name:Noema Pharma AG | |||||||||||||
Full Title: A Phase 2B, Multicenter, 30-week, Prospective, Cross-over, Doubleblind, Randomized, Placebo-controlled Study Followed by a 52-Week Open-label Extension Study to Evaluate the Efficacy and Safety of ... | |||||||||||||
Medical condition: Tuberous Sclerosis Complex | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014892-31 | Sponsor Protocol Number: MAIVECMOPAIN | Start Date*: 2009-11-10 |
Sponsor Name:ErasmusMC - Sophia | ||
Full Title: Morphine intravenous vs. Paracetamol intravenous in children on ECMO | ||
Medical condition: Patients treated with Extra Corporal Membrane Oxygenation (ECMO) receive morphine as standardised analgesic drug. Morphine is associated with several side effects. In these patients a non-opioid dr... | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001542-17 | Sponsor Protocol Number: T109/2019Xe-SAH | Start Date*: 2020-09-17 | |||||||||||
Sponsor Name:Timo Laitio | |||||||||||||
Full Title: Effect of xenon on brain injury, neurological outcome and survival in patients after aneurysmal subarachnoid hemorrhage | |||||||||||||
Medical condition: Acute rupture of cerebral aneurysm, subarachnoid hemorrhage (SAH), unconsciousness, brain injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004854-25 | Sponsor Protocol Number: SPON803-10 | Start Date*: 2012-01-10 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: TRON: A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis. | |||||||||||||
Medical condition: Tuberous Sclerosis Complex (TSC) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006804-12 | Sponsor Protocol Number: ucb L059 | Start Date*: 2007-03-15 | |||||||||||||||||||||
Sponsor Name:ErasmusMedical Center-Sophia | |||||||||||||||||||||||
Full Title: Levetiracetam (Keppra®) in neonates | |||||||||||||||||||||||
Medical condition: epileptic seizures in neonates admitted to the intensive care unit | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004478-80 | Sponsor Protocol Number: Issue1 | Start Date*: 2014-01-08 | |||||||||||||||||||||
Sponsor Name:University Hospital Bristol NHS Foundation Trust | |||||||||||||||||||||||
Full Title: XENON AND COOLING THERAPY IN BABIES AT HIGH RISK OF BRAIN INJURY FOLLOWING POOR CONDITION AT BIRTH: A RANDOMISED OUTCOME STUDY (COOLXENON3 STUDY) | |||||||||||||||||||||||
Medical condition: Neonatal hypoxia-ischaemia (HI). There is no exact MedDRA term for this. The closest MedDRA terms matching this are neonatal asphyxia and neonatal hypoxia. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004286-33 | Sponsor Protocol Number: 1042-0501 | Start Date*: 2007-05-11 | |||||||||||
Sponsor Name:Marinus Pharmceuticals, Inc. | |||||||||||||
Full Title: An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spasms. | |||||||||||||
Medical condition: Infantile spasms | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) PL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005397-34 | Sponsor Protocol Number: Issue1 | Start Date*: 2012-02-24 | |||||||||||||||||||||
Sponsor Name:University Hospital Bristol NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Xenon and cooling therapy in babies at high risk of brain injury following poor condition at birth: Randomised pilot study. (CoolXenon2 study) | |||||||||||||||||||||||
Medical condition: Neonatal hypoxia-ischaemia (HI). There is no exact MedDRA term for this. The closest MedDRA terms matching this are neonatal asphyxia and neonatal hypoxia. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-004285-13 | Sponsor Protocol Number: 1042-0500 | Start Date*: 2007-05-11 | |||||||||||
Sponsor Name:Marinus Pharmaceuticals, Inc. | |||||||||||||
Full Title: A double-blind, placebo-controlled, dose-ranging clinical study to evaluate the safety, tolerability, and antiepileptic activity of ganaxolone in treatment of patients with infantile spasms. | |||||||||||||
Medical condition: Infantile spasms | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005295-33 | Sponsor Protocol Number: S54913 | Start Date*: 2013-03-08 | |||||||||||
Sponsor Name:UZ Leuven-Department of Urology | |||||||||||||
Full Title: Monocentric, open-label, phase III study that compares the efficiency and tolerance between intravesical oxybutynin and oral fesoterodine in children (5-16y) with neurogenic detrusor overactivity. | |||||||||||||
Medical condition: children with neurogenic detrusor overactivity | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004668-71 | Sponsor Protocol Number: 11/0499 | Start Date*: 2014-09-25 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: An Open Label Randomised Controlled Trial of Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission of Childhood Polyarteritis Nodosa | |||||||||||||
Medical condition: Childhood systemic polyarteritis nodosa (PAN) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) PT (Completed) ES (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
